Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Archive
Search for this keyword
Advanced search
Close
More
Main menu
Archive
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
SLE, systemic lupus erythematosus
Email alerts
SLE, systemic lupus erythematosus
Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
Nathalie
Costedoat-Chalumeau
,
Zahir
Amoura
,
Jean-Sébastien
Hulot
,
Guy
Aymard
,
Gaëlle
Leroux
,
Donata
Marra
,
Philippe
Lechat
,
Jean-Charles
Piette
Annals of the Rheumatic Diseases
Jun 2007,
66
(6)
821-824;
DOI:
10.1136/ard.2006.067835
IRF5
rs2004640-T
allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis
Sophie
Garnier
,
Philippe
Dieudé
,
Laetitia
Michou
,
Sandra
Barbet
,
Alice
Tan
,
Sandra
Lasbleiz
,
Thomas
Bardin
,
Bernard
Prum
,
François
Cornélis
Annals of the Rheumatic Diseases
Jun 2007,
66
(6)
828-831;
DOI:
10.1136/ard.2006.061390
Intrathecal immunoglobulin production in patients with systemic lupus erythematosus with neuropsychiatric manifestations
Mo
Yin Mok
,
Eric Y T
Chan
,
Woon
Sing Wong
,
Chak
Sing Lau
Annals of the Rheumatic Diseases
Jun 2007,
66
(6)
846-847;
DOI:
10.1136/ard.2006.061069
Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus
W
Stohl
,
S
Metyas
,
S-M
Tan
,
G S
Cheema
,
B
Oamar
,
V
Roschke
,
Y
Wu
,
K P
Baker
,
D M
Hilbert
Annals of the Rheumatic Diseases
Sep 2004,
63
(9)
1096-1103;
DOI:
10.1136/ard.2003.018663
First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104
C
Iking-Konert
,
S
Stocks
,
F
Weinsberg
,
R
Engelbrecht
,
E
Bleck
,
A
Perniok
,
R
Fischer-Betz
,
S
Pincus
,
L
Nardone
,
M
Schneider
Annals of the Rheumatic Diseases
Sep 2004,
63
(9)
1104-1112;
DOI:
10.1136/ard.2003.016691
Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis
C
Gabler
,
N
Blank
,
T
Hieronymus
,
M
Schiller
,
J H M
Berden
,
J R
Kalden
,
H-M
Lorenz
Annals of the Rheumatic Diseases
Sep 2004,
63
(9)
1135-1144;
DOI:
10.1136/ard.2003.011452
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
I E A
Hoffman
,
I
Peene
,
L
Meheus
,
T W J
Huizinga
,
L
Cebecauer
,
D
Isenberg
,
K
De Bosschere
,
F
Hulstaert
,
E M
Veys
,
F
De Keyser
Annals of the Rheumatic Diseases
Sep 2004,
63
(9)
1155-1158;
DOI:
10.1136/ard.2003.013417
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures
S
Sangle
,
D P
D’Cruz
,
M A
Khamashta
,
G R V
Hughes
Annals of the Rheumatic Diseases
Oct 2004,
63
(10)
1241-1243;
DOI:
10.1136/ard.2003.016105
Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases
E M
Salonen
,
A
Miettinen
,
T K
Walle
,
S
Koskenmies
,
J
Kere
,
H
Julkunen
Annals of the Rheumatic Diseases
Oct 2004,
63
(10)
1250-1254;
DOI:
10.1136/ard.2003.011890
Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus
S
Saevarsdottir
,
H
Kristjansdottir
,
G
Grondal
,
T
Vikingsdottir
,
K
Steinsson
,
H
Valdimarsson
Annals of the Rheumatic Diseases
Nov 2006,
65
(11)
1462-1467;
DOI:
10.1136/ard.2005.046086
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »
CLINICAL
Diagnostics
Clinical diagnostic tests
(1563)
Radiology (diagnostics)
(921)
Surgical diagnostic tests
(505)
Drugs and medicines
Endocrinology
Calcium and bone
(938)
Evidence based practice
Guidelines
(35)
Gastroenterology
Inflammatory bowel disease
(98)
Genetics
(1272)
Immunology (including allergy)
(6648)
Infectious diseases
Bone and joint infections
(93)
Travel medicine
(42)
Neurology
Muscle disease
(198)
Pain (neurology)
(1113)
Nutrition and metabolism
Obesity (nutrition)
(142)
Obstetrics and gynaecology
Menopause (including HRT)
(60)
Ophthalmology
(155)
Orthopaedics
Pathology
Inflammation
(1572)
Pathology
(531)
Pharmacology and therapeutics
Unwanted effects / adverse reactions
(15)
Pharmacology and therapeutics
Radiology
(1357)
Rehabilitation medicine
Disability
(32)
Other rehabilitative therapies
(18)
Physiotherapy
(52)
Renal medicine
(247)
Respiratory medicine
Interstitial lung disease
(181)
Pulmonary hypertension
(39)
Rheumatology
Ankylosing spondylitis
(567)
Biological agents
(731)
Connective tissue disease
(5506)
Degenerative joint disease
(6038)
Drugs: musculoskeletal and joint diseases
(916)
Fibromyalgia
(51)
Musculoskeletal syndromes
(6412)
Osteoarthritis
(1189)
Osteoporosis
(160)
Rheumatoid arthritis
(4213)
Sjogren's syndrome
(6)
Systemic lupus erythematosus
(724)
Vascularitis
(367)
Sports and exercise medicine
Physiotherapy
(33)
NON-CLINICAL
Epidemiology
(1862)
Health economics
(51)
Medical education
Postgraduate
(5)
Occupational and environmental medicine
(32)
Statistics and research methods
Special collections
ARD Lay summaries
(83)
Editor's choice
(161)
Guidelines, Recommendations and Consensus Statements
Open access
(1199)
Press releases
(50)
